|
Volumn 24, Issue 7, 2002, Pages 637-642
|
“FAR” chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinoma
|
Author keywords
5 fluorouracil; Complete laryngeal preservation; Head and neck cancer; Radiotherapy; Vitamin A; Voice preservation
|
Indexed keywords
FLUOROURACIL;
RETINOL;
ADULT;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER CONTROL;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
GLOTTIS;
HUMAN;
LARYNGECTOMY;
LARYNX CARCINOMA;
MAJOR CLINICAL STUDY;
MALE;
MULTIMODALITY CANCER THERAPY;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIATION ENTEROPATHY;
TREATMENT OUTCOME;
VOICE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIMETABOLITES, ANTINEOPLASTIC;
FEMALE;
FLUOROURACIL;
GLOTTIS;
HUMANS;
LARYNGEAL NEOPLASMS;
LARYNGECTOMY;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
VITAMIN A;
|
EID: 0036301622
PISSN: 10433074
EISSN: None
Source Type: Journal
DOI: 10.1002/hed.10114 Document Type: Article |
Times cited : (27)
|
References (15)
|